Skip to content

PressReach

SEARCH icon
  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos
Search

SEARCH FOR AN ARTICLE

  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos

PressReach

icon

      HomeBiotech

      Biotech

      OraGen®, the first and only viable bone allograft, is now available for dental procedures
      Biotech

      OraGen®, the first and only viable bone allograft, is now available for dental procedures

      February 16, 2025
      Dignify Therapeutics Highlights Clinical Development Plans at BIO CEO & Investor Conference
      Biotech

      Dignify Therapeutics Highlights Clinical Development Plans at BIO CEO & Investor Conference

      February 15, 2025
      AMGEN TO PRESENT AT CITI’S 2025 VIRTUAL ONCOLOGY LEADERSHIP SUMMIT
      Biotech

      AMGEN TO PRESENT AT CITI’S 2025 VIRTUAL ONCOLOGY LEADERSHIP SUMMIT

      February 15, 2025
      Implantica publishes Year-end Report, January – December 2024 (Q4)
      Biotech

      Implantica publishes Year-end Report, January – December 2024 (Q4)

      February 14, 2025
      MAYPHARM CO., LTD. Launches SKINCOLLA: The World’s First Recombinant Human Collagen Filler for Superior Skin Rejuvenation
      Biotech

      MAYPHARM CO., LTD. Launches SKINCOLLA: The World’s First Recombinant Human Collagen Filler for Superior Skin Rejuvenation

      February 14, 2025
      DAAN Biotherapeutics Signs Antibody Exclusive Licensing Agreement with LigaChem Biosciences for ADC (Antibody-Drug Conjugate) Therapeutic Development
      Biotech

      DAAN Biotherapeutics Signs Antibody Exclusive Licensing Agreement with LigaChem Biosciences for ADC (Antibody-Drug Conjugate) Therapeutic Development

      February 13, 2025
      Restore Vision Announces First Patient Dosed in Phase I/II Clinical Trial of RV-001 for Gene-Agnostic Retinitis Pigmentosa
      Biotech

      Restore Vision Announces First Patient Dosed in Phase I/II Clinical Trial of RV-001 for Gene-Agnostic Retinitis Pigmentosa

      February 13, 2025
      Antengene Announces XPOVIO® Approved for Public Health Insurance Coverage in Taiwan Market, Benefiting More Patients with R/R MM in the Region
      Biotech

      Antengene Announces XPOVIO® Approved for Public Health Insurance Coverage in Taiwan Market, Benefiting More Patients with R/R MM in the Region

      February 13, 2025
      Jazz Pharmaceuticals to Report 2024 Full Year and Fourth Quarter Financial Results on February 25, 2025
      Biotech

      Jazz Pharmaceuticals to Report 2024 Full Year and Fourth Quarter Financial Results on February 25, 2025

      February 12, 2025
      Desert Control Releases Q4 2024 Report and Year-to-Date Company Update
      Biotech

      Desert Control Releases Q4 2024 Report and Year-to-Date Company Update

      February 12, 2025
      « 1 … 48 49 50 51 52 … 140 »

       

      LATEST NEWS

      • Health Sanofi Market Potential Boosted by Amvuttra Data

      PressReach

      All logos, trade names and/or trademarks, artwork and associated imagery are trademarks and/or copyright material of their respective owners.

      • Advertisers
      • Privacy Policy
      • Terms of Use
      • DMCA Policy
      • Disclaimer
      • Contact Us

      SUBSCRIBE

      To get email updates from PressReach.

      I want e-mail alerts, updates, and offers and agree to the PressReach privacy policy.

      Market Jar Media Inc. © 2026